{"lastClose": 13.579999923706055, "len": 1191, "date": "2023-02-16", "alpha_1": 0.7509853448983264, "beta_1": 0.8757608034027269, "drawup_1": 1.2434209803960319, "sharpe_1": 0.5904227179521959, "natr_1": 5.069872483727384, "sup_1": -0.16703481679082918, "res_1": 0.04958273120059549, "bullPattern_1": [], "bearPattern_1": ["SHORTLINE"], "rsi_1": 44.50128008236234, "adx_1": 17.24309381193604, "drawdown_1": -0.33391761557680333, "stratHoldSharpe_1": 0.5671061134299394, "stratHoldAlpha_1": 251.3021256002985, "stratHoldDrawdown_1": -0.3006576063229185, "alpha_3mo": -0.540906076662665, "beta_3mo": 0.6654855756811066, "drawup_3mo": 0.09349033384347871, "natr_3mo": 5.069872483727384, "sup_3mo": -0.01855669046077077, "res_3mo": 0.05979383499411713, "bullPattern_3mo": ["LONGLINE"], "bearPattern_3mo": [], "rsi_3mo": 41.27660040727974, "adx_3mo": 22.55510954046764, "drawdown_3mo": -0.209384155693352, "stratHoldSharpe_3mo": -1.5416766295745048, "stratHoldAlpha_3mo": 250.45263883370004, "stratHoldDrawdown_3mo": -0.18968061063489305, "Market Cap": 939374105, "Industry": "Biotechnology: Pharmaceutical Preparations", "Country": "United States", "Sector": "Health Care", "IPO Year": 2018.0, "Name": "Kiniksa Pharmaceuticals Ltd. Class A", "alpha%_1": 0.9963985285840434, "beta%_1": 0.4157886059752204, "drawup%_1": 0.9714808900265691, "sharpe%_1": 0.38332879928822394, "natr%_1": 0.6970928918195389, "drawdown%_1": 0.611862781812812, "stratHoldSharpe%_1": 0.7368885105166683, "stratHoldAlpha%_1": 0.8448860116915684, "stratHoldDrawdown%_1": 0.6187540531783385, "alpha%_3mo": 0.11114275382499411, "beta%_3mo": 0.3048545444327514, "drawup%_3mo": 0.17847145462298053, "natr%_3mo": 0.6910660737299326, "drawdown%_3mo": 0.20852765464167755, "stratHoldSharpe%_3mo": 0.05508068577042041, "stratHoldAlpha%_3mo": 0.05944485681621711, "stratHoldDrawdown%_3mo": 0.20952256239158135}